LRRK2 and Parkinson disease: Here, we review the recent research particularly with respect to LRRK2 in tauopathies, and highlight important questions that need to be addressed as we advance toward disease-modifying therapies as there is emerging evidence that LRRK2 may be a therapeutic target beyond PD.